Target-based Classification of Drugs

[ Brite menu | Download htext | Download json ]
    

1st Level  2nd Level  3rd Level  4th Level  5th Level 

 G Protein-coupled receptors
 
 Ion channels
 
 Nuclear receptors
 
 Protein kinases
   Serine/threonine kinases
   Receptor serine/threonine kinases (RSTK)
   Receptor tyrosine kinases (RTK)
     EGFR family
     INSR family
       INSR (CD220) [HSA:3643] [KO:K04527]
       IGF1R (CD221) [HSA:3480] [KO:K05087]
         D03297  Mecasermin (USAN/INN) <JP/US>
         D04870  Mecasermin rinfabate (USAN/INN)
         D08620  Toremifene (INN)
         D00967  Toremifene citrate (JAN/USAN) <JP/US>
         D09328  Cixutumumab (USAN)
         D09345  Figitumumab (USAN)
         D09680  Teprotumumab (USAN/INN)
         D09746  Dalotuzumab (USAN)
         D09908  Ganitumab (USAN/INN)
         D09925  Linsitinib (USAN/INN)
         D10056  Robatumumab (USAN/INN)
         D10943  Istiratumab (USAN)
       ROS1* [HSA_VAR:6098v1] [HSA:6098] [KO:K05088]
     PDGFR family
     FGFR family
     VEGFR family
     MET family
     TRK family
     EPH family
     AXL family
     ALK family
     TIE family
     RET family
   Non-receptor tyrosine kinases
 
 Cytokines and receptors
 
 Cell surface molecules and ligands
 
 Transporters
 
 Enzymes
 
 Not elsewhere classified

[ DRUG | BRITE | KEGG2 | KEGG ]
Last updated: May 19, 2018

» Monoclonal antibodies only